In out-licensing, responsibilities for product, authorisation, manufacturing and distribution are agreed between Pharma-Zentrale and the licensing partner for each project.
For in-licensing, the group assesses complementary products against its portfolio, quality standards, regulatory framework and market logic.
Together we clarify which modules fit the product, target market and regulatory framework.
Out-licensing
Licensing and distribution models for suitable products and defined markets can be assessed. Availability, registration, branding and contractual responsibilities are aligned for each product and country.
In-licensing
Through in-licensing, Pharma-Zentrale assesses complementary products and product rights for its portfolio. Product quality, regulatory framework, market potential and the allocation of responsibilities between partners are evaluated for each project.
Two licensing routes
In- and out-licensing at a glance.
01
Out-licensing
For suitable products, distribution or usage rights are granted to a licensing partner for defined markets.
02
In-licensing
Complementary products or rights from external partners are assessed for the portfolio and intended markets.
03
Assessment & fit
Quality, authorisation, market potential, manufacturing and strategic fit are reviewed for the respective project.
04
Partnership model
Responsibilities for product, authorisation, manufacturing, brand and distribution are clearly defined by contract.
Related services
Further B2B services.
Development
Formulation and process optimisation at laboratory and pilot scale.
:quality(84):no_upscale())
Contact